Engineered Interactions with Mesoporous Silica Facilitate Intracellular Delivery of Proteins and Gene Editing
- 23 April 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 20 (5), 4014-4021
- https://doi.org/10.1021/acs.nanolett.0c01387
Abstract
Intracellular delivery of functional proteins is a promising, but challenging, strategy for many therapeutic applications. Here, we report a new methodology that overcomes drawbacks of traditional mesoporous silica (MSi) particles for protein delivery. We hypothesize that engineering enhancement in interactions between proteins and delivery vehicles can facilitate efficient encapsulation and intracellular delivery. In this strategy, surface lysines in proteins were modified with a self-immolative linker containing a terminal boronic acid for stimulus-induced reversibility in functionalization. The boronic acid moiety serves to efficiently interact with amine-functionalized MSi through dative and electrostatic interactions. We show that proteins of different sizes and isoelectric points (pIs) can be quantitatively encapsulated into MSi, even at low protein concentrations. We also show that the proteins can be efficiently delivered into cells with retention of activity. Utility of this approach is further demonstrated with gene editing in cells, through the delivery of a CRISPR/Cas 9 complex.Keywords
Funding Information
- National Institute of General Medical Sciences (GM-108556)
This publication has 53 references indexed in Scilit:
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- Boronate-Mediated Biologic DeliveryJournal of the American Chemical Society, 2012
- Tailoring nanocarriers for intracellular protein deliveryChemical Society Reviews, 2011
- Self-immolative linkers in polymeric delivery systemsPolymer Chemistry, 2010
- Design of next-generation protein therapeuticsCurrent Opinion in Chemical Biology, 2010
- Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming ProteinsCell Stem Cell, 2009
- Generation of Induced Pluripotent Stem Cells Using Recombinant ProteinsCell Stem Cell, 2009
- Protein therapeutics: a summary and pharmacological classificationNature Reviews Drug Discovery, 2008
- Mesoporous Silica Nanoparticles for Intracellular Delivery of Membrane-Impermeable ProteinsJournal of the American Chemical Society, 2007
- Recombinant protein therapeutics—success rates, market trends and values to 2010Nature Biotechnology, 2004